Related Experiment Video
Updated: Jun 1, 2026
09:38
A Microfluidic Flow Chamber Model for Platelet Transfusion and Hemostasis Measures Platelet Deposition and Fibrin Formation in Real-time
Published on: February 14, 2017
The molecular mechanisms that control thrombopoiesis
1Department of Medicine, Division of Hematology/Oncology, University of California, San Diego, California 92103-3931, USA. kkaushansky@ucsd.edu
The Journal of Clinical Investigation
|December 3, 2005
Summary
Thrombopoietin is key to blood platelet formation, regulating multiple stages of production. Understanding its mechanisms offers new clinical applications for hematopoiesis.
Area of Science:
- Hematology
- Molecular Biology
- Cell Biology
Background:
- Thrombopoiesis, the formation of blood platelets, is crucial for hemostasis.
- Recent advances have significantly improved our understanding of this process.
- Thrombopoietin (TPO) has been identified as the primary regulator of thrombopoiesis.
Purpose of the Study:
- To review the current understanding of thrombopoiesis, focusing on the role of thrombopoietin.
- To elucidate the molecular and cellular mechanisms by which TPO influences platelet production.
- To highlight the clinical implications of TPO's function in hematopoiesis.
Main Methods:
- Review of recent scientific literature on thrombopoiesis and thrombopoietin.
- Analysis of the known effects of TPO on hematopoietic stem cells (HSCs) and megakaryocyte progenitor cells.
- Discussion of the interplay between intrinsic and extrinsic factors in hematopoiesis.
Main Results:
- Thrombopoietin regulates multiple critical steps in platelet production.
- TPO influences HSC self-renewal and expansion.
- TPO stimulates megakaryocyte progenitor proliferation and maturation into platelet-producing cells.
Conclusions:
- Thrombopoietin is central to regulating nearly all aspects of platelet formation.
- Understanding TPO's mechanisms provides insights into hematopoiesis regulation.
- These insights open new avenues for translating basic research into clinical advancements.
Related Concept Videos
01:01Regulation of Hematopoietic Stem Cells
All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
01:30Anticoagulant Drugs: Low-Molecular-Weight Heparins
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
01:28Role of Hematopoietic Growth Factors
Hematopoietic growth factors are molecules that regulate the differentiation rate of hematopoietic stem cells (HSCs). Erythropoietin (EPO), primarily produced by the kidneys, plays a crucial role in erythrocyte production. When oxygen levels in the blood are low, EPO is released into the bloodstream, reaching the bone marrow, where it stimulates HSCs to differentiate and mature into erythrocytes, which are vital for oxygen transport.
Thrombopoietin (TPO), mainly released by the liver,...
Thrombopoietin (TPO), mainly released by the liver,...
01:18Structure and Function of Platelets
The cell fragments known as platelets are disc-shaped, with an average diameter of about 3 μm and a thickness of roughly 1 μm. They play a crucial role in the body's vascular clotting system, which also involves plasma proteins, blood cells, and blood vessel tissues.
Platelets are continually replenished, circulating in the bloodstream for 9-12 days before being removed by phagocytes, primarily in the spleen. A microliter of circulating blood contains between 150,000 and 450,000 platelets, with...
Platelets are continually replenished, circulating in the bloodstream for 9-12 days before being removed by phagocytes, primarily in the spleen. A microliter of circulating blood contains between 150,000 and 450,000 platelets, with...
01:20Extrinsic and Intrinsic Pathways of Hemostasis
Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which forms a...
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which forms a...
01:24Disorders of Hemostasis
Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.